Altogether, our study highlights a new role for the inflammasome in promoting invasive breast cancer progression by facilitating tumor infiltration with neutrophils, while impeding the NK cell-associated anti-tumoral response independently of IL-1β and IL-18. This evidence concerns the gene IL1B and breast carcinoma.